Consideration of SGLT2 inhibitor treatment in broader T2DM population
AHA 2018 - Chicago, IL, VS
This video was recorded at the congress of the American Heart Association on November 10, 2018, in Chicago, IL, USA.
Steve Wiviott, MD, Brigham and Women's Hospital, Boston, MA, VS.
This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.
Read our summary of the DECLARE TIMI-58 results
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: